Mrinalini Kala

735 total citations
20 papers, 388 citations indexed

About

Mrinalini Kala is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mrinalini Kala has authored 20 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Mrinalini Kala's work include Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (4 papers) and Multiple Sclerosis Research Studies (3 papers). Mrinalini Kala is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (4 papers) and Multiple Sclerosis Research Studies (3 papers). Mrinalini Kala collaborates with scholars based in United States, India and Czechia. Mrinalini Kala's co-authors include Timothy Vollmer, Subrata Sinha, Denise I. Campagnolo, Fu‐Dong Shi, Augusto Miravalle, Wenhua Piao, Kiran Bajaj, Harold A. Chapman, Premkumar Christadoss and Huan Yang and has published in prestigious journals such as The Journal of Immunology, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Mrinalini Kala

18 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mrinalini Kala United States 10 201 113 97 63 38 20 388
Lora Zhao United States 5 138 0.7× 114 1.0× 120 1.2× 76 1.2× 16 0.4× 7 340
Monica van der Vieren United States 8 352 1.8× 104 0.9× 61 0.6× 93 1.5× 27 0.7× 9 630
José Sancho United States 8 181 0.9× 87 0.8× 74 0.8× 40 0.6× 13 0.3× 13 367
Derek Pappas United States 11 145 0.7× 188 1.7× 111 1.1× 17 0.3× 24 0.6× 18 443
Vivienne McConnell United Kingdom 12 75 0.4× 186 1.6× 71 0.7× 65 1.0× 59 1.6× 20 502
Peter Weiser United States 14 343 1.7× 129 1.1× 63 0.6× 143 2.3× 12 0.3× 28 616
A Durántez Spain 14 294 1.5× 164 1.5× 110 1.1× 32 0.5× 43 1.1× 29 620
Qunmin Zhou United States 7 251 1.2× 84 0.7× 62 0.6× 23 0.4× 21 0.6× 8 381
Jiehao Zhou United States 10 85 0.4× 237 2.1× 45 0.5× 44 0.7× 73 1.9× 24 477
Nicole A. Belmar United States 9 320 1.6× 133 1.2× 111 1.1× 88 1.4× 16 0.4× 16 584

Countries citing papers authored by Mrinalini Kala

Since Specialization
Citations

This map shows the geographic impact of Mrinalini Kala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mrinalini Kala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mrinalini Kala more than expected).

Fields of papers citing papers by Mrinalini Kala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mrinalini Kala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mrinalini Kala. The network helps show where Mrinalini Kala may publish in the future.

Co-authorship network of co-authors of Mrinalini Kala

This figure shows the co-authorship network connecting the top 25 collaborators of Mrinalini Kala. A scholar is included among the top collaborators of Mrinalini Kala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mrinalini Kala. Mrinalini Kala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kala, Mrinalini, Erin Kelley, John A. Altin, et al.. (2025). Identification of Coccidioidomycosis Immunoreactive Peptides That Recall T-Cell Responses Indicating Past Exposure. The Journal of Infectious Diseases. 231(6). 1619–1628.
3.
Bixby, Billie, Lukáš Vrba, Marc M. Oshiro, et al.. (2024). Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid. Scientific Reports. 14(1). 2939–2939. 3 indexed citations
4.
Yi, Dan, Bin Liu, Hongxu Ding, et al.. (2023). E2F1 Mediates SOX17 Deficiency–Induced Pulmonary Hypertension. Hypertension. 80(11). 2357–2371. 9 indexed citations
5.
Kala, Mrinalini, et al.. (2023). Carbon nanotube stimulation of human mononuclear cells to model granulomatous inflammation.. PubMed. 15(3). 1704–1714. 4 indexed citations
6.
Gardner, Colin, Mrinalini Kala, Timothy Marlowe, et al.. (2023). PTK2-associated gene signature could predict the prognosis of IPF. Respiratory Research. 24(1). 304–304. 6 indexed citations
7.
Bapat, Aditi, Xiaojian Shi, Paniz Jasbi, et al.. (2021). Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts. Experimental Hematology. 97. 32–46.e35. 23 indexed citations
8.
Kala, Mrinalini, Augusto Miravalle, & Timothy Vollmer. (2011). Recent insights into the mechanism of action of glatiramer acetate. Journal of Neuroimmunology. 235(1-2). 9–17. 54 indexed citations
9.
Bomprezzi, Roberto, Rejane Schaefer, Van Reese, et al.. (2011). Glatiramer Acetate‐Specific Antibody Titres in Patients with Relapsing / Remitting Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis. Scandinavian Journal of Immunology. 74(3). 219–226. 10 indexed citations
10.
Kala, Mrinalini, et al.. (2009). B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Experimental Neurology. 221(1). 136–145. 88 indexed citations
11.
Piao, Wenji, Youngheun Jee, Stephen W. Coons, et al.. (2007). IL‐21 Modulates CD4+ CD25+ Regulatory T‐Cell Homeostasis in Experimental Autoimmune Encephalomyelitis. Scandinavian Journal of Immunology. 67(1). 37–46. 47 indexed citations
12.
Hlobílková, Alice, et al.. (2007). Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?. PubMed. 54(4). 334–41. 14 indexed citations
13.
Yang, Huan, et al.. (2005). Cathepsin S Is Required for Murine Autoimmune Myasthenia Gravis Pathogenesis. The Journal of Immunology. 174(3). 1729–1737. 52 indexed citations
14.
Kala, Mrinalini, Chun‐Rong Chen, Sandra M. McLachlan, et al.. (2005). Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease. Immunology. 116(4). 532–540. 5 indexed citations
15.
Saini, Deepti, Mrinalini Kala, Vishal Jain, & Subrata Sinha. (2005). Targeting the active site of the placental isozyme of alkaline phosphatase by phage-displayed scFv antibodies selected by a specific uncompetitive inhibitor. BMC Biotechnology. 5(1). 14 indexed citations
16.
Bose, Biplab, et al.. (2003). Characterization and molecular modeling of a highly stable anti-Hepatitis B surface antigen scFv. Molecular Immunology. 40(9). 617–631. 20 indexed citations
17.
Kala, Mrinalini, et al.. (2002). Phage Displayed Antibodies to Heat Stable Alkaline Phosphatase: Framework Region as a Determinant of Specificity. The Journal of Biochemistry. 132(4). 535–541. 5 indexed citations
18.
Kala, Mrinalini, Kiran Bajaj, & Subrata Sinha. (2001). Direct Antigen Capture by Soluble scFv Antibodies. Applied Biochemistry and Biotechnology. 90(1). 11–22. 9 indexed citations
19.
Kala, Mrinalini, Kiran Bajaj, & Subrata Sinha. (1997). Magnetic Bead Enzyme-Linked Immunosorbent Assay (ELISA) Detects Antigen-Specific Binding by Phage-Displayed scFv Antibodies That Are Not Detected with Conventional ELISA. Analytical Biochemistry. 254(2). 263–266. 23 indexed citations
20.
Ehrmann, Jiří, et al.. (1995). Expression of p53 in glioblastoma multiforme cells: relationship to survival, proliferation and glycosylation.. PubMed. 31(3). 87–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026